These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 4256645
1. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects. Ogston D, Douglas AS. Drugs; 1971; 1(3):228-46. PubMed ID: 4256645 [No Abstract] [Full Text] [Related]
2. Studies on the mechanism of action of inhibitors of the fibrinolysin system. Ambrus CM, Ambrus JL, Lassman HB, Mink IB. Ann N Y Acad Sci; 1968 Jun 28; 146(2):430-47. PubMed ID: 4239437 [No Abstract] [Full Text] [Related]
3. The hematologic consequences of thrombolytic therapy. Fletcher AP, Alkjaersig NK. Prog Hematol; 1986 Jun 28; 14():183-200. PubMed ID: 2935903 [No Abstract] [Full Text] [Related]
4. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism. Kwaan HC. Thromb Diath Haemorrh Suppl; 1973 Jun 28; 56():239-51. PubMed ID: 4617331 [No Abstract] [Full Text] [Related]
5. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins]. Delsart D, Chambefort V, Decousus H. Rev Prat; 2001 Sep 01; 51(13):1489-97. PubMed ID: 11601082 [No Abstract] [Full Text] [Related]
6. Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis. Steele P, Ellis J, Genton E. Am J Med; 1978 Mar 01; 64(3):441-5. PubMed ID: 345802 [No Abstract] [Full Text] [Related]
7. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?]. Roĭtman EV, Dement'eva II, Meshcheriakov AV. Anesteziol Reanimatol; 1997 Mar 01; (6):65-9. PubMed ID: 9511253 [No Abstract] [Full Text] [Related]
8. Fibrinogen turnover and drugs acting on fibrinolysis. De Nicola P. Acta Univ Carol Med Monogr; 1972 Mar 01; 52():25-31. PubMed ID: 4544612 [No Abstract] [Full Text] [Related]
10. [Biochemical basis for the control of anticoagulant and thrombolytic therapy]. Markwardt F. Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Mar 01; 94(2):116-28. PubMed ID: 4098766 [No Abstract] [Full Text] [Related]
11. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems. Isacson S, Nilsson IM. Scand J Haematol; 1970 Mar 01; 7(5):404-8. PubMed ID: 5486783 [No Abstract] [Full Text] [Related]
12. Fibrinolytic agents. Sherry S. Dis Mon; 1969 May 01; ():3-32. PubMed ID: 4241828 [No Abstract] [Full Text] [Related]
13. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients]. Zabolotskikh IB, Sin'kov SV, Klevko VA. Anesteziol Reanimatol; 2001 May 01; (2):70-5. PubMed ID: 11494909 [No Abstract] [Full Text] [Related]
14. [Current state of anticoagulant and fibrinolytic therapy]. Hladovec J. Cas Lek Cesk; 1971 Oct 15; 110(42):969-75. PubMed ID: 5114558 [No Abstract] [Full Text] [Related]